Description
Jevtana is used to treat patients with prostate cancer who were previously treated with a regimen that consisted of docetaxel.
Fact Table |
Formula |
C45H57NO14 |
License |
US DailyMed, US FDA, EU EMA |
Bioavailability |
56.6% |
Legal status |
Rx-Only |
Chemical Name |
Cabazitaxel |
Elimination half-life |
95 hours |
Dosage (Strength) |
- |
Pregnancy |
Consult Doctor |
Brands |
Jevtana |
Protein binding |
89% to 92% |
PubChem CID |
9854073 |
MedlinePlus |
a611009 |
ChEBI |
63584 |
ATC code |
L01CD04 |
DrugBank |
DB06772 |
KEGG |
D09755 |
Routes of administration |
Intravenous |
Directions
Any questions or concerns about Jevtana may be referred to your doctor.
Your doctor or other qualified healthcare provider will administer your Jevtana and instruct you on how often you should receive the intravenous infusion.
Ingredients
The active ingredient in Jevtana is cabazitaxel. The inactive ingredients include polysorbate 80 and citric acid monohydrate.
Contraindications
Jevtana should not be administered to patients with an allergy to the medication or to polysorbate 80, severe liver problems, or blood cell counts that are 1500/mm3 or less.
Cautions
Jevtana contains the following FDA Boxed Warnings:
- Neutropenic deaths have occurred. Blood counts should be obtained frequently. Jevtana should not be administered to patients with neutrophil counts that are 1,500/mm3 or less. High-risk patients or patients receiving 25 mg/m2 of Jevtana may receive primary prophylaxis with G-CSF.
- Jevtana can cause severe allergic reactions that result in rash, redness, low blood pressure, and difficulty breathing. Jevtana should be stopped and appropriate therapy initiated if a patient experiences any of these effects.
- Patients with severe allergic reactions to cabazitaxel or other drugs that contain polysorbate 80 should not receive Jevtana.
- Before you begin receiving Jevtana, tell your doctor about:
- All the prescription and over-the-counter medications you take
- Your allergies
- Your current health conditions and past medical history
- Your pregnancy or breastfeeding status
- Abnormal blood counts and bone marrow suppression can occur with Jevtana use. Blood counts should be frequently obtained.
- Patients who are 65 years of age and older may be at increased risk for toxicities, which can be fatal or cause serious adverse reactions.
- Nausea, vomiting, and diarrhea can occur. Death associated with diarrhea has occurred.
- Kidney failure, liver problems, urinary disorders, and respiratory disorders can occur.
- Jevtana can cause harm to an unborn baby or cause loss of pregnancy. Effective contraceptive methods should be used.
Side Effects
Abnormal cell counts, anemia, diarrhea, nausea, fatigue, weakness, vomiting, blood in the urine, constipation, decreased appetite, back pain, and stomach pain are common Jevtana side effects. However, these are not the only side effects that can occur. Call your doctor right away if you have side effects that bother you or won’t go away.
Reference
Jevtana. Bridgewater, NJ: sanofi-aventis U.S. LLC; 2021.
About Dr. Savannah Muncy (Page Author)
Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13939